The DOI matches its Crossref record; 552 of the 552 references it cites were found in a registry or an index.
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Open accessAbstract
The stimulator of interferon genes (STING) cellular signaling pathway is a promising target for cancer immunotherapy. Activation of the intracellular STING protein triggers the production of a multifaceted array of immunostimulatory molecules, which, in the proper context, can drive dendritic cell maturation, antitumor macrophage polarization, T cell priming and activation, natural killer cell activation, vascular reprogramming, and/or cancer cell death, resulting in immune-mediated tumor elimination and generation of antitumor immune memory. Accordingly, there is a significant amount of ongoing preclinical and clinical research toward further understanding the role of the STING pathway in cancer immune surveillance as well as the development of modulators of the pathway as a strategy to stimulate antitumor immunity. Yet, the efficacy of STING pathway agonists is limited by many drug delivery and pharmacological challenges. Depending on the class of STING agonist and the desired administration route, these may include poor drug stability, immunocellular toxicity, immune-related adverse events, limited tumor or lymph node targeting and/or retention, low cellular uptake and intracellular delivery, and a complex dependence on the magnitude and kinetics of STING signaling. This review provides a concise summary of the STING pathway, highlighting recent biological developments, immunological consequences, and implications for drug delivery. This review also offers a critical analysis of an expanding arsenal of chemical strategies that are being employed to enhance the efficacy, safety, and/or clinical utility of STING pathway agonists and lastly draws attention to several opportunities for therapeutic advancements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 552
Structure and Function of the Interferon- Enhanceosome
MANIATIS, T., FALVO, J. V., KIM, T. H., KIM, T. K., LIN, C. H., PAREKH, B. S., & WATHELET, M. G. (1998) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1998.63.609 · Cited by 358
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
Diamond, J. M., Vanpouille-Box, C., Spada, S., Rudqvist, N.-P., Chapman, J. R., Ueberheide, B. M., Pilones, K. A., Sarfraz, Y., Formenti, S. C., & Demaria, S. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0581 · Cited by 358
Carozza, J. A., Böhnert, V., Nguyen, K. C., Skariah, G., Shaw, K. E., Brown, J. A., Rafat, M., von Eyben, R., Graves, E. E., Glenn, J. S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0028-4 · Cited by 357
VRACs and other ion channels and transporters in the regulation of cell volume and beyond
Jentsch, T. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.29 · Cited by 353
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Smith, T. T., Moffett, H. F., Stephan, S. B., Opel, C. F., Dumigan, A. G., Jiang, X., Pillarisetty, V. G., Pillai, S. P. S., Wittrup, K. D., & Stephan, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87624 · Cited by 336
STING pathway agonism as a cancer therapeutic
Flood, B. A., Higgs, E. F., Li, S., Luke, J. J., & Gajewski, T. F. (2019) · Immunological Reviews · doi:10.1111/imr.12765 · Cited by 334
SLC19A1 is an importer of the immunotransmitter cGAMP.
Ritchie, C., Cordova, A. F., Hess, G. T., Bassik, M. C., & Li, L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.006 · Cited by 333
The AIM 2 inflammasome: Sensor of pathogens and cellular perturbations
Lugrin, J., & Martinon, F. (2018) · Immunological Reviews · doi:10.1111/imr.12618 · Cited by 333
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Chabanon, R. M., Muirhead, G., Krastev, D. B., Adam, J., Morel, D., Garrido, M., Lamb, A., Hénon, C., Dorvault, N., Rouanne, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123319 · Cited by 332
Krauss, A. C., Gao, X., Li, L., Manning, M. L., Patel, P., Fu, W., Janoria, K. G., Gieser, G., Bateman, D. A., Przepiorka, D., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2990 · Cited by 332
Zhao, Z., Ma, Z., Wang, B., Guan, Y., Su, X.-D., & Jiang, Z. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108053 · Cited by 328
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Zheng, J., Mo, J., Zhu, T., Zhuo, W., Yi, Y., Hu, S., Yin, J., Zhang, W., Zhou, H., & Liu, Z. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01250-1 · Cited by 326
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Lemos, H., Mohamed, E., Huang, L., Ou, R., Pacholczyk, G., Arbab, A. S., Munn, D., & Mellor, A. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1456 · Cited by 325
Lara, P. N., Douillard, J.-Y., Nakagawa, K., von Pawel, J., McKeage, M. J., Albert, I., Losonczy, G., Reck, M., Heo, D.-S., Fan, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.0660 · Cited by 323
Wu, J., Chen, Y.-J., Dobbs, N., Sakai, T., Liou, J., Miner, J. J., & Yan, N. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182192 · Cited by 323
Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
Park, C. G., Hartl, C. A., Schmid, D., Carmona, E. M., Kim, H.-J., & Goldberg, M. S. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar1916 · Cited by 321
Transmission of innate immune signaling by packaging of cGAMP in viral particles
Gentili, M., Kowal, J., Tkach, M., Satoh, T., Lahaye, X., Conrad, C., Boyron, M., Lombard, B., Durand, S., Kroemer, G., et al. (2015) · Science · doi:10.1126/science.aab3628 · Cited by 320
Lo, C. G., Xu, Y., Proia, R. L., & Cyster, J. G. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041509 · Cited by 319
Agonist-Mediated Activation of STING Induces Apoptosis in Malignant B Cells
Tang, C.-H. A., Zundell, J. A., Ranatunga, S., Lin, C., Nefedova, Y., Del Valle, J. R., & Hu, C.-C. A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1885 · Cited by 319
Kitai, Y., Kawasaki, T., Sueyoshi, T., Kobiyama, K., Ishii, K. J., Zou, J., Akira, S., Matsuda, T., & Kawai, T. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601694 · Cited by 318
Immunity in response to particulate antigen-delivery systems
STORNI, T., KUNDIG, T., SENTI, G., & JOHANSEN, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.008 · Cited by 317
Prolonged activation of innate immune pathways by a polyvalent STING agonist
Li, S., Luo, M., Wang, Z., Feng, Q., Wilhelm, J., Wang, X., Li, W., Wang, J., Cholka, A., Fu, Y.-X., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00675-9 · Cited by 317
Selective Transcription in Response to an Inflammatory Stimulus
Smale, S. T. (2010) · Cell · doi:10.1016/j.cell.2010.01.037 · Cited by 315
STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
Yang, H., Lee, W. S., Kong, S. J., Kim, C. G., Kim, J. H., Chang, S. K., Kim, S., Kim, G., Chon, H. J., & Kim, C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125413 · Cited by 313
Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
Li, J., Duran, M. A., Dhanota, N., Chatila, W. K., Bettigole, S. E., Kwon, J., Sriram, R. K., Humphries, M. P., Salto-Tellez, M., James, J. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0387 · Cited by 312
Manganese-Based Nanoactivator Optimizes Cancer Immunotherapy via Enhancing Innate Immunity
Hou, L., Tian, C., Yan, Y., Zhang, L., Zhang, H., & Zhang, Z. (2020) · ACS Nano · doi:10.1021/acsnano.9b06111 · Cited by 309
cGAS is activated by DNA in a length‐dependent manner
Luecke, S., Holleufer, A., Christensen, M. H., Jønsson, K. L., Boni, G. A., Sørensen, L. K., Johannsen, M., Jakobsen, M. R., Hartmann, R., & Paludan, S. R. (2017) · EMBO reports · doi:10.15252/embr.201744017 · Cited by 308
Wang, F., Su, H., Xu, D., Dai, W., Zhang, W., Wang, Z., Anderson, C. F., Zheng, M., Oh, R., Wan, F., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0597-7 · Cited by 308
Dooley, K., McConnell, R. E., Xu, K., Lewis, N. D., Haupt, S., Youniss, M. R., Martin, S., Sia, C. L., McCoy, C., Moniz, R. J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.020 · Cited by 307
Wei, X., Shao, B., He, Z., Ye, T., Luo, M., Sang, Y., Liang, X., Wang, W., Luo, S., Yang, S., et al. (2015) · Cell Research · doi:10.1038/cr.2015.9 · Cited by 306
Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Wang, J., Li, P., Yu, Y., Fu, Y., Jiang, H., Lu, M., Sun, Z., Jiang, S., Lu, L., & Wu, M. X. (2020) · Science · doi:10.1126/science.aau0810 · Cited by 306
Small molecules targeting the innate immune cGAS‒STING‒TBK1 signaling pathway
Ding, C., Song, Z., Shen, A., Chen, T., & Zhang, A. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.03.001 · Cited by 306
Li, W., Lu, L., Lu, J., Wang, X., Yang, C., Jin, J., Wu, L., Hong, X., Li, F., Cao, D., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9013 · Cited by 305
Kato, Y., Park, J., Takamatsu, H., Konaka, H., Aoki, W., Aburaya, S., Ueda, M., Nishide, M., Koyama, S., Hayama, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-212988 · Cited by 304
Tight nuclear tethering of cGAS is essential for preventing autoreactivity
Volkman, H. E., Cambier, S., Gray, E. E., & Stetson, D. B. (2019) · eLife · doi:10.7554/elife.47491 · Cited by 303
Lama, L., Adura, C., Xie, W., Tomita, D., Kamei, T., Kuryavyi, V., Gogakos, T., Steinberg, J. I., Miller, M., Ramos-Espiritu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08620-4 · Cited by 303
STING Recognition of Cytoplasmic DNA Instigates Cellular Defense
Abe, T., Harashima, A., Xia, T., Konno, H., Konno, K., Morales, A., Ahn, J., Gutman, D., & Barber, G. N. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.039 · Cited by 299
Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
Cerboni, S., Jeremiah, N., Gentili, M., Gehrmann, U., Conrad, C., Stolzenberg, M.-C., Picard, C., Neven, B., Fischer, A., Amigorena, S., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161674 · Cited by 299
Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
Schadt, L., Sparano, C., Schweiger, N. A., Silina, K., Cecconi, V., Lucchiari, G., Yagita, H., Guggisberg, E., Saba, S., Nascakova, Z., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.065 · Cited by 298
McWhirter, S. M., Barbalat, R., Monroe, K. M., Fontana, M. F., Hyodo, M., Joncker, N. T., Ishii, K. J., Akira, S., Colonna, M., Chen, Z. J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082874 · Cited by 296
Metalloimmunology: The metal ion-controlled immunity
(2020) · Advances in Immunology · doi:10.1016/bs.ai.2019.11.007 · Cited by 292
Zhou, C., Chen, X., Planells-Cases, R., Chu, J., Wang, L., Cao, L., Li, Z., López-Cayuqueo, K. I., Xie, Y., Ye, S., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.016 · Cited by 291
G3BP1 promotes DNA binding and activation of cGAS
Liu, Z.-S., Cai, H., Xue, W., Wang, M., Xia, T., Li, W.-J., Xing, J.-Q., Zhao, M., Huang, Y.-J., Chen, S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0262-4 · Cited by 290
Trial watch: STING agonists in cancer therapy
Le Naour, J., Zitvogel, L., Galluzzi, L., Vacchelli, E., & Kroemer, G. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1777624 · Cited by 289
STING-dependent sensing of self-DNA drives silica-induced lung inflammation
Benmerzoug, S., Rose, S., Bounab, B., Gosset, D., Duneau, L., Chenuet, P., Mollet, L., Le Bert, M., Lambers, C., Geleff, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07425-1 · Cited by 284
High-Efficiency Transfection of Primary Human and Mouse T Lymphocytes Using RNA Electroporation
Zhao, Y., Zheng, Z., Cohen, C. J., Gattinoni, L., Palmer, D. C., Restifo, N. P., Rosenberg, S. A., & Morgan, R. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.688 · Cited by 283
Harrington, K. J., Brody, J., Ingham, M., Strauss, J., Cemerski, S., Wang, M., Tse, A., Khilnani, A., Marabelle, A., & Golan, T. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy424.015 · Cited by 280
A Circular RNA Protects Dormant Hematopoietic Stem Cells from DNA Sensor cGAS-Mediated Exhaustion
Xia, P., Wang, S., Ye, B., Du, Y., Li, C., Xiong, Z., Qu, Y., & Fan, Z. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.016 · Cited by 280
STAT1 as a key modulator of cell death
Kim, H. S., & Lee, M.-S. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.09.003 · Cited by 279
Cyclic di-GMP Sensing via the Innate Immune Signaling Protein STING
Yin, Q., Tian, Y., Kabaleeswaran, V., Jiang, X., Tu, D., Eck, M. J., Chen, Z. J., & Wu, H. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.029 · Cited by 278
Grabosch, S., Bulatovic, M., Zeng, F., Ma, T., Zhang, L., Ross, M., Brozick, J., Fang, Y., Tseng, G., Kim, E., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0581-9 · Cited by 278
Evolutionary Origins of cGAS-STING Signaling
Margolis, S. R., Wilson, S. C., & Vance, R. E. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.03.004 · Cited by 276
Konno, H., Yamauchi, S., Berglund, A., Putney, R. M., Mulé, J. J., & Barber, G. N. (2018) · Oncogene · doi:10.1038/s41388-017-0120-0 · Cited by 274
The STING pathway and the T cell-inflamed tumor microenvironment
Woo, S.-R., Corrales, L., & Gajewski, T. F. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.003 · Cited by 271
Barnett, K. C., Coronas-Serna, J. M., Zhou, W., Ernandes, M. J., Cao, A., Kranzusch, P. J., & Kagan, J. C. (2019) · Cell · doi:10.1016/j.cell.2019.01.049 · Cited by 271
Yi, G., Brendel, V. P., Shu, C., Li, P., Palanathan, S., & Cheng Kao, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077846 · Cited by 270
A Modified Polyriboinosinic-Polyribocytidylic Acid Complex That Induces Interferon in Primates
Levy, H. B., Baer, G., Baron, S., Buckler, C. E., Gibbs, C. J., Iadarola, M. J., London, W. T., & Rice, J. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.4.434 · Cited by 270
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Yang, X., Zhang, X., Fu, M. L., Weichselbaum, R. R., Gajewski, T. F., Guo, Y., & Fu, Y.-X. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.004 · Cited by 269
NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists
Nicolai, C. J., Wolf, N., Chang, I.-C., Kirn, G., Marcus, A., Ndubaku, C. O., McWhirter, S. M., & Raulet, D. H. (2020) · Science Immunology · doi:10.1126/sciimmunol.aaz2738 · Cited by 268
Jiang, H., Xue, X., Panda, S., Kawale, A., Hooy, R. M., Liang, F., Sohn, J., Sung, P., & Gekara, N. O. (2019) · The EMBO Journal · doi:10.15252/embj.2019102718 · Cited by 266
cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection
Orzalli, M. H., Broekema, N. M., Diner, B. A., Hancks, D. C., Elde, N. C., Cristea, I. M., & Knipe, D. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424637112 · Cited by 265
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
Hou, Y., Liang, H., Rao, E., Zheng, W., Huang, X., Deng, L., Zhang, Y., Yu, X., Xu, M., Mauceri, H., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.008 · Cited by 265
Paquette, R. L., Hsu, N. C., Kiertscher, S. M., Park, A. N., Tran, L., Roth, M. D., & Glaspy, J. A. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.358 · Cited by 262
Gasdermin D Restrains Type I Interferon Response to Cytosolic DNA by Disrupting Ionic Homeostasis
Banerjee, I., Behl, B., Mendonca, M., Shrivastava, G., Russo, A. J., Menoret, A., Ghosh, A., Vella, A. T., Vanaja, S. K., Sarkar, S. N., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.006 · Cited by 261
Cheng, N., Watkins-Schulz, R., Junkins, R. D., David, C. N., Johnson, B. M., Montgomery, S. A., Peine, K. J., Darr, D. B., Yuan, H., McKinnon, K. P., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120638 · Cited by 260
Baird, J. R., Friedman, D., Cottam, B., Dubensky, T. W., Kanne, D. B., Bambina, S., Bahjat, K., Crittenden, M. R., & Gough, M. J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3619 · Cited by 257
Nakamura, T., Sato, T., Endo, R., Sasaki, S., Takahashi, N., Sato, Y., Hyodo, M., Hayakawa, Y., & Harashima, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002852 · Cited by 257
Herzner, A.-M., Hagmann, C. A., Goldeck, M., Wolter, S., Kübler, K., Wittmann, S., Gramberg, T., Andreeva, L., Hopfner, K.-P., Mertens, C., et al. (2015) · Nature Immunology · doi:10.1038/ni.3267 · Cited by 256
Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy
Koshy, S. T., Cheung, A. S., Gu, L., Graveline, A. R., & Mooney, D. J. (2017) · Advanced Biosystems · doi:10.1002/adbi.201600013 · Cited by 256
STING activation in cancer immunotherapy
Su, T., Zhang, Y., Valerie, K., Wang, X.-Y., Lin, S., & Zhu, G. (2019) · Theranostics · doi:10.7150/thno.37574 · Cited by 256
Liu, Y., Crowe, W. N., Wang, L., Lu, Y., Petty, W. J., Habib, A. A., & Zhao, D. (2019) · Nature Communications · doi:10.1038/s41467-019-13094-5 · Cited by 254
Controlling timing and location in vaccines
Irvine, D. J., Aung, A., & Silva, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.019 · Cited by 254
cGAS/STING axis mediates a topoisomerase II inhibitor–induced tumor immunogenicity
Wang, Z., Chen, J., Hu, J., Zhang, H., Xu, F., He, W., Wang, X., Li, M., Lu, W., Zeng, G., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127471 · Cited by 253
Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response
Li, T., Cheng, H., Yuan, H., Xu, Q., Shu, C., Zhang, Y., Xu, P., Tan, J., Rui, Y., Li, P., et al. (2016) · Scientific Reports · doi:10.1038/srep19049 · Cited by 253
Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles
Cai, S., Yang, Q., Bagby, T. R., & Forrest, M. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.017 · Cited by 252
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Moyer, T. J., Kato, Y., Abraham, W., Chang, J. Y. H., Kulp, D. W., Watson, N., Turner, H. L., Menis, S., Abbott, R. K., Bhiman, J. N., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0753-3 · Cited by 252
Aulisa, L., Dong, H., & Hartgerink, J. D. (2009) · Biomacromolecules · doi:10.1021/bm900634x · Cited by 251
Cytosolic DNA Sensing in Organismal Tumor Control
Vanpouille-Box, C., Demaria, S., Formenti, S. C., & Galluzzi, L. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.013 · Cited by 250
Viruses transfer the antiviral second messenger cGAMP between cells
Bridgeman, A., Maelfait, J., Davenne, T., Partridge, T., Peng, Y., Mayer, A., Dong, T., Kaever, V., Borrow, P., & Rehwinkel, J. (2015) · Science · doi:10.1126/science.aab3632 · Cited by 249
TREX1 Deficiency Triggers Cell-Autonomous Immunity in a cGAS-Dependent Manner
Ablasser, A., Hemmerling, I., Schmid-Burgk, J. L., Behrendt, R., Roers, A., & Hornung, V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400737 · Cited by 249
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
Thompson, E. D., Enriquez, H. L., Fu, Y.-X., & Engelhard, V. H. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092454 · Cited by 249
Ancient Origin of cGAS-STING Reveals Mechanism of Universal 2′,3′ cGAMP Signaling
Kranzusch, P. J., Wilson, S. C., Lee, A. S. Y., Berger, J. M., Doudna, J. A., & Vance, R. E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.022 · Cited by 248
Beyond Oil and Water—Phase Transitions in Cells
Hyman, A. A., & Simons, K. (2012) · Science · doi:10.1126/science.1223728 · Cited by 248
Luo, W.-W., Li, S., Li, C., Lian, H., Yang, Q., Zhong, B., & Shu, H.-B. (2016) · Nature Immunology · doi:10.1038/ni.3510 · Cited by 248
Gentili, M., Lahaye, X., Nadalin, F., Nader, G. P. F., Puig Lombardi, E., Herve, S., De Silva, N. S., Rookhuizen, D. C., Zueva, E., Goudot, C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.105 · Cited by 248
Trial watch: TLR3 agonists in cancer therapy
Le Naour, J., Galluzzi, L., Zitvogel, L., Kroemer, G., & Vacchelli, E. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1771143 · Cited by 239
Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
Koutsakos, M., Illing, P. T., Nguyen, T. H. O., Mifsud, N. A., Crawford, J. C., Rizzetto, S., Eltahla, A. A., Clemens, E. B., Sant, S., Chua, B. Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0320-6 · Cited by 239
Qiao, J. T., Cui, C., Qing, L., Wang, L. S., He, T. Y., Yan, F., Liu, F. Q., Shen, Y. H., Hou, X. G., & Chen, L. (2018) · Metabolism · doi:10.1016/j.metabol.2017.09.010 · Cited by 238
Barriers and Strategies of Cationic Liposomes for Cancer Gene Therapy
Liu, C., Zhang, L., Zhu, W., Guo, R., Sun, H., Chen, X., & Deng, N. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.07.015 · Cited by 236
Phosphorylation and chromatin tethering prevent cGAS activation during mitosis
Li, T., Huang, T., Du, M., Chen, X., Du, F., Ren, J., & Chen, Z. J. (2021) · Science · doi:10.1126/science.abc5386 · Cited by 236
Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP
Shang, G., Zhu, D., Li, N., Zhang, J., Zhu, C., Lu, D., Liu, C., Yu, Q., Zhao, Y., Xu, S., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2332 · Cited by 233
Future of nanotherapeutics: Targeting the cellular sub-organelles
Ma, X., Gong, N., Zhong, L., Sun, J., & Liang, X.-J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.026 · Cited by 233
Phase separation in immune signalling
Xiao, Q., McAtee, C. K., & Su, X. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00572-5 · Cited by 230
Cyclic Dinucleotides and the Innate Immune Response
Danilchanka, O., & Mekalanos, J. J. (2013) · Cell · doi:10.1016/j.cell.2013.08.014 · Cited by 228
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Storozynsky, Q., & Hitt, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228877 · Cited by 228
Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts
Miller, M. A., Chandra, R., Cuccarese, M. F., Pfirschke, C., Engblom, C., Stapleton, S., Adhikary, U., Kohler, R. H., Mohan, J. F., Pittet, M. J., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal0225 · Cited by 225
STING Signaling Promotes Inflammation in Experimental Acute Pancreatitis
Zhao, Q., Wei, Y., Pandol, S. J., Li, L., & Habtezion, A. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.065 · Cited by 225
Xia, P., Ye, B., Wang, S., Zhu, X., Du, Y., Xiong, Z., Tian, Y., & Fan, Z. (2016) · Nature Immunology · doi:10.1038/ni.3356 · Cited by 222
Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling
Lepelley, A., Martin-Niclós, M. J., Le Bihan, M., Marsh, J. A., Uggenti, C., Rice, G. I., Bondet, V., Duffy, D., Hertzog, J., Rehwinkel, J., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200600 · Cited by 222
Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
Wilson, D. R., Sen, R., Sunshine, J. C., Pardoll, D. M., Green, J. J., & Kim, Y. J. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.10.013 · Cited by 220
Prantner, D., Perkins, D. J., Lai, W., Williams, M. S., Sharma, S., Fitzgerald, K. A., & Vogel, S. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382986 · Cited by 216
Marabelle, A., Andtbacka, R., Harrington, K., Melero, I., Leidner, R., de Baere, T., Robert, C., Ascierto, P. A., Baurain, J. F., Imperiale, M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy423 · Cited by 215
The structural basis for the sensing and binding of cyclic di-GMP by STING
Huang, Y.-H., Liu, X.-Y., Du, X.-X., Jiang, Z.-F., & Su, X.-D. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2333 · Cited by 213
Ackerman, S. E., Pearson, C. I., Gregorio, J. D., Gonzalez, J. C., Kenkel, J. A., Hartmann, F. J., Luo, A., Ho, P. Y., LeBlanc, H., Blum, L. K., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00136-x · Cited by 213
Akt Kinase-Mediated Checkpoint of cGAS DNA Sensing Pathway
Seo, G. J., Yang, A., Tan, B., Kim, S., Liang, Q., Choi, Y., Yuan, W., Feng, P., Park, H.-S., & Jung, J. U. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.007 · Cited by 212
Chitosan but Not Chitin Activates the Inflammasome by a Mechanism Dependent upon Phagocytosis
Bueter, C. L., Lee, C. K., Rathinam, V. A. K., Healy, G. J., Taron, C. H., Specht, C. A., & Levitz, S. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274936 · Cited by 209
cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing
Zhou, W., Mohr, L., Maciejowski, J., & Kranzusch, P. J. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.024 · Cited by 209
Xie, W., Lama, L., Adura, C., Tomita, D., Glickman, J. F., Tuschl, T., & Patel, D. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905013116 · Cited by 208
BAF restricts cGAS on nuclear DNA to prevent innate immune activation
Guey, B., Wischnewski, M., Decout, A., Makasheva, K., Kaynak, M., Sakar, M. S., Fierz, B., & Ablasser, A. (2020) · Science · doi:10.1126/science.aaw6421 · Cited by 208
Ho, S. S. W., Zhang, W. Y. L., Tan, N. Y. J., Khatoo, M., Suter, M. A., Tripathi, S., Cheung, F. S. G., Lim, W. K., Tan, P. H., Ngeow, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.010 · Cited by 207
Biological role of connexin intercellular channels and hemichannels
Kar, R., Batra, N., Riquelme, M. A., & Jiang, J. X. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.008 · Cited by 206
The lymph node microenvironment and its role in the progression of metastatic cancer
Pereira, E. R., Jones, D., Jung, K., & Padera, T. P. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.01.008 · Cited by 204
Molecular evolutionary and structural analysis of the cytosolic DNA sensor cGAS and STING
Wu, X., Wu, F.-H., Wang, X., Wang, L., Siedow, J. N., Zhang, W., & Pei, Z.-M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku569 · Cited by 204
Role of the cGAS–STING pathway in cancer development and oncotherapeutic approaches
Khoo, L. T., & Chen, L. (2018) · The EMBO Reports · doi:10.15252/embr.201846935 · Cited by 204
A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome
Deng, Z., Chong, Z., Law, C. S., Mukai, K., Ho, F. O., Martinu, T., Backes, B. J., Eckalbar, W. L., Taguchi, T., & Shum, A. K. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201045 · Cited by 203
PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1
Yoh, S. M., Schneider, M., Seifried, J., Soonthornvacharin, S., Akleh, R. E., Olivieri, K. C., De Jesus, P. D., Ruan, C., de Castro, E., Ruiz, P. A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.050 · Cited by 202
Chelvanambi, M., Fecek, R. J., Taylor, J. L., & Storkus, W. J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001906 · Cited by 201
The mammalian PYHIN gene family: Phylogeny, evolution and expression
Cridland, J. A., Curley, E. Z., Wykes, M. N., Schroder, K., Sweet, M. J., Roberts, T. L., Ragan, M. A., Kassahn, K. S., & Stacey, K. J. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-140 · Cited by 200
The STING phase-separator suppresses innate immune signalling
Yu, X., Zhang, L., Shen, J., Zhai, Y., Jiang, Q., Yi, M., Deng, X., Ruan, Z., Fang, R., Chen, Z., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00659-0 · Cited by 200
ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment
Dillon, M. T., Bergerhoff, K. F., Pedersen, M., Whittock, H., Crespo-Rodriguez, E., Patin, E. C., Pearson, A., Smith, H. G., Paget, J. T. E., Patel, R. R., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1821 · Cited by 199
TMEM173 Drives Lethal Coagulation in Sepsis
Zhang, H., Zeng, L., Xie, M., Liu, J., Zhou, B., Wu, R., Cao, L., Kroemer, G., Wang, H., Billiar, T. R., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.004 · Cited by 199
Lu, X., Miao, L., Gao, W., Chen, Z., McHugh, K. J., Sun, Y., Tochka, Z., Tomasic, S., Sadtler, K., Hyacinthe, A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6606 · Cited by 199
Nakamura, T., Miyabe, H., Hyodo, M., Sato, Y., Hayakawa, Y., & Harashima, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.026 · Cited by 198
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy
Leach, D. G., Dharmaraj, N., Piotrowski, S. L., Lopez-Silva, T. L., Lei, Y. L., Sikora, A. G., Young, S., & Hartgerink, J. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.035 · Cited by 196
Vascular regulation of antitumor immunity
Munn, L. L., & Jain, R. K. (2019) · Science · doi:10.1126/science.aaw7875 · Cited by 195
Rewcastle, G. W., Atwell, G. J., Zhuang, L., Baguley, B. C., & Denny, W. A. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a034 · Cited by 194
Species‐specific detection of the antiviral small‐molecule compound CMA by STING
Cavlar, T., Deimling, T., Ablasser, A., Hopfner, K., & Hornung, V. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.86 · Cited by 194
LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP
Lahey, L. J., Mardjuki, R. E., Wen, X., Hess, G. T., Ritchie, C., Carozza, J. A., Böhnert, V., Maduke, M., Bassik, M. C., & Li, L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.021 · Cited by 194
Downey, C. M., Aghaei, M., Schwendener, R. A., & Jirik, F. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099988 · Cited by 193
BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors
Reisländer, T., Lombardi, E. P., Groelly, F. J., Miar, A., Porru, M., Di Vito, S., Wright, B., Lockstone, H., Biroccio, A., Harris, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11048-5 · Cited by 192
Lymphatic Migration of Immune Cells
Hampton, H. R., & Chtanova, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01168 · Cited by 191
Meric-Bernstam, F., Sandhu, S. K., Hamid, O., Spreafico, A., Kasper, S., Dummer, R., Shimizu, T., Steeghs, N., Lewis, N., Talluto, C. C., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.2507 · Cited by 190
Falahat, R., Berglund, A., Putney, R. M., Perez-Villarroel, P., Aoyama, S., Pilon-Thomas, S., Barber, G. N., & Mulé, J. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013598118 · Cited by 190
Roemer, M. G. M., Advani, R. H., Redd, R. A., Pinkus, G. S., Natkunam, Y., Ligon, A. H., Connelly, C. F., Pak, C. J., Carey, C. D., Daadi, S. E., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0201 · Cited by 189
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells
Ahn, J., Xia, T., Rabasa Capote, A., Betancourt, D., & Barber, G. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.027 · Cited by 189
Kalamvoki, M., Du, T., & Roizman, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419338111 · Cited by 188
cGAS-like receptors sense RNA and control 3′2′-cGAMP signalling in Drosophila
Slavik, K. M., Morehouse, B. R., Ragucci, A. E., Zhou, W., Ai, X., Chen, Y., Li, L., Wei, Z., Bähre, H., König, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03743-5 · Cited by 188
DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer
Paludan, S. R., Reinert, L. S., & Hornung, V. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0117-0 · Cited by 186
Intrinsic Self-DNA Triggers Inflammatory Disease Dependent on STING
Ahn, J., Ruiz, P., & Barber, G. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401337 · Cited by 184
Yoshida, T., Goto, S., Kawakatsu, M., Urata, Y., & Li, T.-S. (2012) · Free Radical Research · doi:10.3109/10715762.2011.645207 · Cited by 184
Ramanathan, R. K., Korn, R. L., Raghunand, N., Sachdev, J. C., Newbold, R. G., Jameson, G., Fetterly, G. J., Prey, J., Klinz, S. G., Kim, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1990 · Cited by 183
Pharmacological modulation of nucleic acid sensors - therapeutic potential and persisting obstacles
Vanpouille-Box, C., Hoffmann, J. A., & Galluzzi, L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0043-2 · Cited by 183
T Cell Trafficking through Lymphatic Vessels
Hunter, M. C., Teijeira, Á., & Halin, C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00613 · Cited by 182
Anticancer Flavonoids Are Mouse-Selective STING Agonists
Kim, S., Li, L., Maliga, Z., Yin, Q., Wu, H., & Mitchison, T. J. (2013) · ACS Chemical Biology · doi:10.1021/cb400264n · Cited by 181
Old dogs, new trick: classic cancer therapies activate cGAS
Yum, S., Li, M., & Chen, Z. J. (2020) · Cell Research · doi:10.1038/s41422-020-0346-1 · Cited by 181
Ager, C. R., Reilley, M. J., Nicholas, C., Bartkowiak, T., Jaiswal, A. R., & Curran, M. A. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0049 · Cited by 180
Ribas, A., Medina, T., Kirkwood, J. M., Zakharia, Y., Gonzalez, R., Davar, D., Chmielowski, B., Campbell, K. M., Bao, R., Kelley, H., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0425 · Cited by 180
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Lam, A. R., Le Bert, N., Ho, S. S. W., Shen, Y. J., Tang, M. L. F., Xiong, G. M., Croxford, J. L., Koo, C. X., Ishii, K. J., Akira, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1703 · Cited by 179
MacFarlane, A. W., Jillab, M., Plimack, E. R., Hudes, G. R., Uzzo, R. G., Litwin, S., Dulaimi, E., Al-Saleem, T., & Campbell, K. S. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0133 · Cited by 177
Pizzolla, A., Nguyen, T. H. O., Sant, S., Jaffar, J., Loudovaris, T., Mannering, S. I., Thomas, P. G., Westall, G. P., Kedzierska, K., & Wakim, L. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96957 · Cited by 176
Dubensky, T. W., Kanne, D. B., & Leong, M. L. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613501988 · Cited by 175
Wang-Bishop, L., Wehbe, M., Shae, D., James, J., Hacker, B. C., Garland, K., Chistov, P. P., Rafat, M., Balko, J. M., & Wilson, J. T. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000282 · Cited by 175
Self-citationThe cGAS-STING Pathway for DNA Sensing
Xiao, T. S., & Fitzgerald, K. A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.004 · Cited by 174
Crosstalk between cGAS–STING signaling and cell death
Murthy, A. M. V., Robinson, N., & Kumar, S. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-00624-8 · Cited by 174
Stimulus-cleavable chemistry in the field of controlled drug delivery
Xue, Y., Bai, H., Peng, B., Fang, B., Baell, J., Li, L., Huang, W., & Voelcker, N. H. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01061h · Cited by 173
Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy
Morrone, S. R., Wang, T., Constantoulakis, L. M., Hooy, R. M., Delannoy, M. J., & Sohn, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313577111 · Cited by 172
STING signaling and host defense against microbial infection
Ahn, J., & Barber, G. N. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0333-0 · Cited by 171
Morrone, S. R., Matyszewski, M., Yu, X., Delannoy, M. R., Egelman, E. H., & Sohn, J. (2015) · Nature Communications · doi:10.1038/ncomms8827 · Cited by 170
Single-Cell Imaging of Caspase-1 Dynamics Reveals an All-or-None Inflammasome Signaling Response
Liu, T., Yamaguchi, Y., Shirasaki, Y., Shikada, K., Yamagishi, M., Hoshino, K., Kaisho, T., Takemoto, K., Suzuki, T., Kuranaga, E., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.012 · Cited by 169
Nanoparticle‐Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
Jin, Q., Zhu, W., Zhu, J., Zhu, J., Shen, J., Liu, Z., Yang, Y., & Chen, Q. (2021) · Advanced Materials · doi:10.1002/adma.202007557 · Cited by 169
Mitochondrial DNA in the regulation of innate immune responses
Fang, C., Wei, X., & Wei, Y. (2016) · Protein & Cell · doi:10.1007/s13238-015-0222-9 · Cited by 168
Mitochondrial permeability transition triggers the release of mtDNA fragments
Patrushev, M., Kasymov, V., Patrusheva, V., Ushakova, T., Gogvadze, V., & Gaziev, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4424-1 · Cited by 168
Positive Feedback Regulation of Type I IFN Production by the IFN-Inducible DNA Sensor cGAS
Ma, F., Li, B., Liu, S.-Y., Iyer, S. S., Yu, Y., Wu, A., & Cheng, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402066 · Cited by 166
Bukowski, R. M., Tendler, C., Cutler, D., Rose, E., Laughlin, M. M., & Statkevich, P. (2002) · Cancer · doi:10.1002/cncr.10663 · Cited by 166
The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response
Wang, Q., Huang, L., Hong, Z., Lv, Z., Mao, Z., Tang, Y., Kong, X., Li, S., Cui, Y., Liu, H., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006264 · Cited by 166
Homeostatic regulation of STING by retrograde membrane traffic to the ER
Mukai, K., Ogawa, E., Uematsu, R., Kuchitsu, Y., Kiku, F., Uemura, T., Waguri, S., Suzuki, T., Dohmae, N., Arai, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20234-9 · Cited by 165
Two cGAS-like receptors induce antiviral immunity in Drosophila
Holleufer, A., Winther, K. G., Gad, H. H., Ai, X., Chen, Y., Li, L., Wei, Z., Deng, H., Liu, J., Frederiksen, N. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03800-z · Cited by 165
A new adjuvant delivery system ‘cyclic di-GMP/YSK05 liposome’ for cancer immunotherapy
Miyabe, H., Hyodo, M., Nakamura, T., Sato, Y., Hayakawa, Y., & Harashima, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.004 · Cited by 163
Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation
Ma, C., Yang, D., Wang, B., Wu, C., Wu, Y., Li, S., Liu, X., Lassen, K., Dai, L., & Yang, S. (2020) · Science Advances · doi:10.1126/sciadv.aaz6717 · Cited by 163
Agonists and inhibitors of the STING pathway: Potential agents for immunotherapy
Wu, J., Zhao, L., Hu, H., Li, W., & Li, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21649 · Cited by 162
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
Jang, S. C., Economides, K. D., Moniz, R. J., Sia, C. L., Lewis, N., McCoy, C., Zi, T., Zhang, K., Harrison, R. A., Lim, J., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02004-5 · Cited by 162
Cordova, A. F., Ritchie, C., Böhnert, V., & Li, L. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00440 · Cited by 162
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
Coffelt, S. B., & de Visser, K. E. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.006 · Cited by 161
Ubiquitination of STING at lysine 224 controls IRF3 activation
Ni, G., Konno, H., & Barber, G. N. (2017) · Science Immunology · doi:10.1126/sciimmunol.aah7119 · Cited by 161
Tumor Microenvironment Targeted Nanotherapy
Fernandes, C., Suares, D., & Yergeri, M. C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01230 · Cited by 161
Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA
Corrales, L. P., Woo, S., Williams, J. B., McWhirter, S. M., Dubensky, T. W., & Gajewski, T. F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502538 · Cited by 160
Lin, L. C., Huang, C., Yao, B., Lin, J., Agrawal, A., Algaissi, A., Peng, B., Liu, Y., Huang, P., Juang, R., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807616 · Cited by 160
Shae, D., Baljon, J. J., Wehbe, M., Christov, P. P., Becker, K. W., Kumar, A., Suryadevara, N., Carson, C. S., Palmer, C. R., Knight, F. C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02765 · Cited by 160
Self-citationCabral, H., Makino, J., Matsumoto, Y., Mi, P., Wu, H., Nomoto, T., Toh, K., Yamada, N., Higuchi, Y., Konishi, S., et al. (2015) · ACS Nano · doi:10.1021/nn5070259 · Cited by 159
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Liang, J., Wang, H., Ding, W., Huang, J., Zhou, X., Wang, H., Dong, X., Li, G., Chen, E., Zhou, F., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc3646 · Cited by 159
Spectrum and Mechanisms of Inflammasome Activation by Chitosan
Bueter, C. L., Lee, C. K., Wang, J. P., Ostroff, G. R., Specht, C. A., & Levitz, S. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301695 · Cited by 158
Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation
Gullà, A., Morelli, E., Samur, M., Botta, C., Hideshima, T., Bianchi, G., Fulciniti, M., Malvestiti, S., PRABHALA, R. H., Talluri, S., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0047 · Cited by 156
Qin, X.-Q., Tao, N., Dergay, A., Moy, P., Fawell, S. E., Davis, A. R., Wilson, J. M., & Barsoum, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14411 · Cited by 155
Self-citationTMEM173 variants and potential importance to human biology and disease
Patel, S., & Jin, L. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0029-9 · Cited by 155
McKee, A. S., Burchill, M. A., Munks, M. W., Jin, L., Kappler, J. W., Friedman, R. S., Jacobelli, J., & Marrack, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300392110 · Cited by 152
Junkins, R. D., Gallovic, M. D., Johnson, B. M., Collier, M. A., Watkins-Schulz, R., Cheng, N., David, C. N., McGee, C. E., Sempowski, G. D., Shterev, I. D., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.030 · Cited by 151
Molecular structure in biomolecular condensates
Peran, I., & Mittag, T. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.09.007 · Cited by 151
Gravina, G. L., Festuccia, C., Marampon, F., Popov, V. M., Pestell, R. G., ZANI, B. M., & Tombolini, V. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-305 · Cited by 148
Mori, A., Oleszycka, E., Sharp, F. A., Coleman, M. M., Ozasa, Y., Singh, M., O’Hagan, D. T., Tajber, L., Corrigan, O. I., McNeela, E. A., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242372 · Cited by 146
Wang, C., Sun, Z., Zhao, C., Zhang, Z., Wang, H., Liu, Y., Guo, Y., Zhang, B., Gu, L., Yu, Y., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.036 · Cited by 146
Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease
Ahn, J., & Barber, G. N. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.009 · Cited by 144
Diverse roles of STING-dependent signaling on the development of cancer
Ahn, J., Konno, H., & Barber, G. N. (2015) · Oncogene · doi:10.1038/onc.2014.457 · Cited by 142
Zhang, F., Stephan, S. B., Ene, C., Smith, T. T., Holland, E. C., & Stephan, M. T. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0306 · Cited by 142
Muñoz, N. M., Williams, M. L., Dixon, K. A., Dupuis, C. J., McWatters, A., Avritscher, R., Manrique, S. Z., McHugh, K. J., Murthy, R., Tam, A. L., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001800 · Cited by 140
Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
Man, F., Lammers, T., & de Rosales, R. T. M. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1255-2 · Cited by 139
Intracellular bacteria engage a STING–TBK1–MVB12b pathway to enable paracrine cGAS–STING signalling
Nandakumar, R., Tschismarov, R., Meissner, F., Prabakaran, T., Krissanaprasit, A., Farahani, E., Zhang, B., Assil, S., Martin, A., Bertrams, W., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0367-z · Cited by 137
ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response
Lian, H., Wei, J., Zang, R., Ye, W., Yang, Q., Zhang, X., Chen, Y.-D., Fu, Y.-Z., Hu, M., Lei, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05559-w · Cited by 133
Wehbe, M., Wang-Bishop, L., Becker, K. W., Shae, D., Baljon, J. J., He, X., Christov, P. P., Boyd, K. L., Balko, J. M., & Wilson, J. T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.017 · Cited by 132
Self-citationChattopadhyay, S., Liu, Y.-H., Fang, Z.-S., Lin, C.-L., Lin, J., Yao, B., & Hu, C. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04094 · Cited by 130
Lioux, T., Mauny, M.-A., Lamoureux, A., Nicolas, B., Hays, M., Vernejoul, F., Baudru, A.-S., Boularan, C., Lopes-Vicente, J., Qushair, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01300 · Cited by 129
Cited by
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja-Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 307
PANoptosis: Mechanisms, biology, and role in disease
Sun, X., Yang, Y., Meng, X., Li, J., Liu, X., & Liu, H. (2024) · Immunological Reviews · doi:10.1111/imr.13279 · Cited by 305
Metadata
- Authors
- Garland, K. M., Sheehy, T. L., & Wilson, J. T.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-02-02
- Volume
- 122
- Issue
- 6
- Pages
- 5977-6039
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W4210772725
- Cited by
- 357
- References
- 552
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.